Linaclotide dose guide

A peptide dosage chart, one peptide at a time: its dose range, how often it’s taken, a typical run and the units on your syringe. 84 peptides from the PepVault library.

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.

Linaclotide dosage

A daily capsule (Linzess) for chronic constipation and IBS with constipation: a small peptide that stays in the gut and draws water into the bowel so stools come more easily. In its trials more bowel movements came in the first week, and about 1 in 6 to 1 in 5 people reached its strict response bar against 3 to 6% on placebo. Commonly reported: looser stools or diarrhea in the first two weeks, gas and bloating. FDA-approved since 2012; constipation from a GLP-1 drug was not what its trials studied.

Dose range
72–290 mcg (fda label).
How often
Daily: Daily, oral
A typical run
Ongoing. FDA-approved for ongoing daily use; its placebo-controlled trials ran 12 to 26 weeks, and open-label trials followed people on 290 mcg for up to 18 months, where 29% needed a dose reduction or pause, mostly for diarrhea.
How it’s taken
Taken by mouth: Oral capsule
Evidence
Established: Clinical trials or FDA-approved use exists
Half-life
Not measurable: it acts in the gut and stays below detection in the blood (FDA label)

Linaclotide on your syringe

Taken by mouth, so there’s nothing to draw.

Newsletter · Weekly

The weekly peptide briefing.

New guides, the week’s peptide news, one tool. Free, one email a week, unsubscribe anytime.

We’ll email you a link to confirm. Your address is used for the briefing only. Privacy

Track the doses you run

PepVault logs every dose, keeps count of the doses left in your vials, and reminds you on your schedule.

Get PepVault on the App Store7 days free on the yearly plan for new subscribers.

More healing peptides

A community reference, not medical advice. Each range is what has been studied or is commonly run, never a dose for you.